Pharma Quality Excellence Awards 2024: A Night of Elegance and Triumph

In the glistening ambiance of success and camaraderie, the stage was set for an evening of unparalleled splendor and distinction as the maiden edition of Pharma Quality Excellence Awards 2024 unfolded in all its grandeur.

Pharma Giant Novartis To Acquire Mariana Oncology For USD 1 Billion

Novartis, a leading innovative medicines company, has announced its intention to acquire Mariana Oncology, a US-based biotechnology firm that specializes in the development of novel radioligand therapies (RLTs) to treat cancers with a high unmet...

ClearPoint Neuro Bags US FDA Nod For Prism Bone Anchor Accessory

ClearPoint Neuro, a global therapy-enabling platform, and quality treatment empowering organization offering exact route to the brain and spine, declared it has secured 510(k) approval for its Prism Bone Anchor Accessory. The company's second new...

Pfizer & Genmab’s Tivdak Bags US FDA Nod to Treat Cervical Cancer

Pfizer Inc, a pharmaceutical industry firm and Genmab A/S reported that the US Food and Drug Administration (FDA) endorses the supplemental Biologics License Application (sBLA) giving full endorsement for Tivdak (tisotumab vedotin-tftv) for the...

Neurocrine Secures FDA Approval of Ingrezza's Sprinkle Capsules

The US FDA endorsed the utilization of a sprinkle case plan of Neurocrine Biosciences Ingrezza (valbenazine) for the treatment of tardive dyskinesia and chorea in Huntington's illness. The US FDA endorsed the utilization of a sprinkle case plan.....

Astellas and Poseida Ink Pact To Develop Novel Allogeneic Cell Therapies

Japanese Astellas Pharma Inc. and Poseida Therapeutics, Inc. declared that Xyphos Biosciences, Inc., and Poseida have gone into a research collaboration and permit consent to foster novel convertibleCAR® programs by consolidating the creative cell...

© 2024 India Pharma Outlook. All Rights Reserved.